Breast Cancer
New Study Further Supports Safety of Promensil(R) as a Natural, Effective Way to Manage Mild-to-Moderate Menopausal Symptoms
Published in Clinical Oncology Week, April 28th, 2008
Natrol, Inc., the exclusive U.S. licensee for Promensil(R) and a premier marketer and manufacturer of nationally branded nutritional products, announces the results of a large, three-year study -- published in the journal Menopause International -- reinforcing the safety of this red clover isoflavone supplement for managing hot flashes and other menopausal symptoms.(1)(a)
Furthermore, this new study shows that Promensil, containing a standardized supplement of red clover isoflavones, has a neutral effect on breast density in women with a family history of breast cancer. This is in contrast to studies showing that some conventional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Breast Cancer
Breast cancer risk amplified by additional genes in combo with BRCA mutation - Breast Cancer
Variants of vitamin D receptor linked to increased risk of breast cancer - Cancer
Inherited cancer mutation is widespread in America - Cancer
Many captive tigers are of purebred ancestry; finding raises their conservation value - Cancer
SNM congratulates NOPR and its supporting organizations on successful conclusion of project - Angiogenesis
Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs from Fractionated Radiation; Reduces Angiogenesis and Inflammation - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
